Lynn Seely
CIK 1327111 · President and CEO · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.17M
Companies
5
Total Filings
71
Lifetime Open-Market Net
-$37.71M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYEL | President and CEO | 74,266 | $13.50 | $1.00M | -$169.8K | 12 | 2026-02-12 |
| Blueprint Medicines Corp (BPMC) Delisted | Director | 13,254 | $129.46 | $1.72M | $0 | 13 | 2025-07-21 |
| Myovant Sciences Ltd. (MYOV) Delisted | Principal Executive Officer | 1,889,992 | $26.98 | $50.99M | $0 | 5 | 2020-04-07 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Medical Officer | 96,694 | — | — | -$37.38M | 40 | 2015-02-18 |
| MDV | Chief Medical Officer | 9,000 | $18.35 | $165.2K | -$160.2K | 1 | 2007-03-20 |
Recent Filings · Page 2 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-14 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +2,242 | $0 | EDGAR |
| 2024-02-13 | LYEL | Grant (A) | +200,000 | $0 | EDGAR |
| 2023-11-20 | LYEL | Mixed | — | $0 | EDGAR |
| 2023-06-23 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +2,600 | $0 | EDGAR |
| 2022-12-19 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2022-06-30 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +2,600 | $0 | EDGAR |
| 2022-06-10 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +2,250 | $0 | EDGAR |
| 2020-06-26 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +2,250 | $0 | EDGAR |
| 2020-06-23 | Blueprint Medicines Corp (BPMC) Delisted | Exer (M) | +1,312 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.